ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ITCI Intra Cellular Therapies Inc

68.49
-2.49 (-3.51%)
29 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Intra Cellular Therapies Inc NASDAQ:ITCI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.49 -3.51% 68.49 67.50 78.86 71.77 67.69 71.01 13,809,590 01:00:00

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

10/06/2024 1:00pm

GlobeNewswire Inc.


Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart


From May 2024 to Jun 2024

Click Here for more Intra Cellular Therapies Charts.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 45th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2024 at 10:00 a.m. ET in Miami, FL.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular TherapiesIntra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:Intra-Cellular Therapies, Inc.Juan Sanchez, M.D.Vice President, Corporate Communications and Investor Relations646-440-9333

Burns McClellan, Inc.Cameron Radinovic cradinovic@burnsmc.com 646-930-4406

1 Year Intra Cellular Therapies Chart

1 Year Intra Cellular Therapies Chart

1 Month Intra Cellular Therapies Chart

1 Month Intra Cellular Therapies Chart